Literature DB >> 19366573

Small protective fragments of the Yersinia pestis V antigen.

Claire Vernazza1, Bry Lingard, Helen C Flick-Smith, Leslie W J Baillie, Jim Hill, Helen S Atkins.   

Abstract

Yersinia pestis is the causative agent of plague. Naturally occurring cases of the disease and the potential use of Y. pestis as a bioweapon fuel the need for efficacious vaccines. The most recent plague vaccine is a killed whole cell preparation that is expensive to manufacture and its side effects are common. The protective antigens F1 and V have been identified and are currently being developed as a combined subunit vaccine. Protective epitopes of the V antigen have previously been shown to reside in the central part of the protein. In order to identify the minimum protective fragment of the V antigen that can provide protection against plague, the structures of several small fragments of the antigen were modelled in silico and recombinant proteins were produced. These fragments were probed for the retention of a protective epitope using a protective monoclonal antibody and protection against Y. pestis in mice was determined. The smallest protective fragment of V antigen identified comprised amino acids 135-262. Finally the ability of this fragment to confer protection when given in the context of a DNA vaccine was confirmed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19366573     DOI: 10.1016/j.vaccine.2009.03.011

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

Review 1.  Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.

Authors:  David G Thanassi; James B Bliska; Peter J Christie
Journal:  FEMS Microbiol Rev       Date:  2012-05-24       Impact factor: 16.408

2.  Amino acid and structural variability of Yersinia pestis LcrV protein.

Authors:  Andrey P Anisimov; Svetlana V Dentovskaya; Evgeniy A Panfertsev; Tat'yana E Svetoch; Pavel Kh Kopylov; Brent W Segelke; Adam Zemla; Maxim V Telepnev; Vladimir L Motin
Journal:  Infect Genet Evol       Date:  2009-10-14       Impact factor: 3.342

3.  Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar typhimurium vaccine induces protection against a lethal Y. pestis challenge in mice.

Authors:  Ascención Torres-Escobar; María Dolores Juárez-Rodríguez; Bronwyn M Gunn; Christine G Branger; Steven A Tinge; Roy Curtiss
Journal:  Infect Immun       Date:  2010-03-22       Impact factor: 3.441

Review 4.  Potential human immunotherapeutics for plague.

Authors:  Voahangy Andrianaivoarimanana; Lovasoa Nomena Randriantseheno; Kristoffer M Moore; Nicola J Walker; Steven G Lonsdale; Sarah Kempster; Neil A Almond; Minoarisoa Rajerison; E Diane Williamson
Journal:  Immunother Adv       Date:  2021-10-05

5.  Amino acid residues 196-225 of LcrV represent a plague protective epitope.

Authors:  Lauriane E Quenee; Bryan J Berube; Joshua Segal; Derek Elli; Nancy A Ciletti; Deborah Anderson; Olaf Schneewind
Journal:  Vaccine       Date:  2009-12-10       Impact factor: 3.641

6.  Dual-function antibodies to Yersinia pestis LcrV required for pulmonary clearance of plague.

Authors:  Nicholas A Eisele; Deborah M Anderson
Journal:  Clin Vaccine Immunol       Date:  2009-10-14

7.  Direct neutralization of type III effector translocation by the variable region of a monoclonal antibody to Yersinia pestis LcrV.

Authors:  Maya I Ivanov; Jim Hill; James B Bliska
Journal:  Clin Vaccine Immunol       Date:  2014-03-05

8.  Characterization of systemic and pneumonic murine models of plague infection using a conditionally virulent strain.

Authors:  Gabriela Mellado-Sanchez; Karina Ramirez; Cinthia B Drachenberg; Jovita Diaz-McNair; Ana L Rodriguez; James E Galen; James P Nataro; Marcela F Pasetti
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2012-11-26       Impact factor: 2.268

9.  Modified needle-tip PcrV proteins reveal distinct phenotypes relevant to the control of type III secretion and intoxication by Pseudomonas aeruginosa.

Authors:  Hiromi Sato; Meredith L Hunt; Joshua J Weiner; Andrew T Hansen; Dara W Frank
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

10.  Multi-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative Bacteria.

Authors:  Hiromi Sato; Dara W Frank
Journal:  Front Microbiol       Date:  2011-07-04       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.